Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.

Magnoni F, Massari G, Santomauro G, Bagnardi V, Pagan E, Peruzzotti G, Galimberti V, Veronesi P, Sacchini VS.

Br J Surg. 2019 Feb 21. doi: 10.1002/bjs.11079. [Epub ahead of print] Review.

PMID:
30791092
2.

Sex-based differences of the Tumor mutational burden and T-cell inflammation of the tumor microenvironment.

Conforti F, Pala L, Bagnardi V, Viale G, De Pas T, Pagan E, Gelber RD, Goldhirsch A.

Ann Oncol. 2019 Jan 29. doi: 10.1093/annonc/mdz034. [Epub ahead of print] No abstract available.

PMID:
30698647
3.

Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation.

Rizzo S, Raimondi S, de Jong EEC, van Elmpt W, De Piano F, Petrella F, Bagnardi V, Jochems A, Bellomi M, Dingemans AM, Lambin P.

Eur J Radiol. 2019 Jan;110:148-155. doi: 10.1016/j.ejrad.2018.11.032. Epub 2018 Nov 28.

PMID:
30599853
4.

Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis.

Di Sandro S, Bagnardi V, Najjar M, Buscemi V, Lauterio A, De Carlis R, Danieli M, Pinotti E, Benuzzi L, De Carlis L.

Surg Oncol. 2018 Dec;27(4):722-729. doi: 10.1016/j.suronc.2018.10.001. Epub 2018 Oct 3.

PMID:
30449499
5.

Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis.

Lugo A, Peveri G, Bosetti C, Bagnardi V, Crippa A, Orsini N, Rota M, Gallus S.

Eur J Cancer. 2018 Nov;104:117-126. doi: 10.1016/j.ejca.2018.09.007. Epub 2018 Oct 19. Review.

PMID:
30347287
6.

Oncological Outcomes of Nipple-Sparing Mastectomy: A Single-Center Experience of 1989 Patients.

Galimberti V, Morigi C, Bagnardi V, Corso G, Vicini E, Fontana SKR, Naninato P, Ratini S, Magnoni F, Toesca A, Kouloura A, Rietjens M, De Lorenzi F, Vingiani A, Veronesi P.

Ann Surg Oncol. 2018 Dec;25(13):3849-3857. doi: 10.1245/s10434-018-6759-0. Epub 2018 Sep 17.

PMID:
30225833
8.

Sex as a predictor of response to cancer immunotherapy - Authors' reply.

Conforti F, Pala L, Bagnardi V, De Pas T, Marco M, Viale G, Gelber R, Goldhirsch A.

Lancet Oncol. 2018 Aug;19(8):e380-e381. doi: 10.1016/S1470-2045(18)30535-7. No abstract available.

PMID:
30102230
9.

Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial.

Montagna E, Bagnardi V, Cancello G, Sangalli C, Pagan E, Iorfida M, Mazza M, Mazzarol G, Dellapasqua S, Munzone E, Goldhirsch A, Colleoni M.

Breast Care (Basel). 2018 Jul;13(3):177-181. doi: 10.1159/000487630. Epub 2018 Apr 26.

PMID:
30069178
10.

Liver Grafts From Donors After Circulatory Death on Regional Perfusion With Extended Warm Ischemia Compared With Donors After Brain Death.

De Carlis R, Di Sandro S, Lauterio A, Botta F, Ferla F, Andorno E, Bagnardi V, De Carlis L.

Liver Transpl. 2018 Nov;24(11):1523-1535. doi: 10.1002/lt.25312.

PMID:
30022597
11.

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.

Conforti F, Pala L, Bagnardi V, De Pas T, Martinetti M, Viale G, Gelber RD, Goldhirsch A.

Lancet Oncol. 2018 Jun;19(6):737-746. doi: 10.1016/S1470-2045(18)30261-4. Epub 2018 May 16.

PMID:
29778737
12.

Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome.

Mazzanti A, Maragna R, Vacanti G, Monteforte N, Bloise R, Marino M, Braghieri L, Gambelli P, Memmi M, Pagan E, Morini M, Malovini A, Ortiz M, Sacilotto L, Bellazzi R, Monserrat L, Napolitano C, Bagnardi V, Priori SG.

J Am Coll Cardiol. 2018 Apr 17;71(15):1663-1671. doi: 10.1016/j.jacc.2018.01.078.

PMID:
29650123
13.

Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer.

Palazzo A, Dellapasqua S, Munzone E, Bagnardi V, Mazza M, Cancello G, Ghisini R, Iorfida M, Montagna E, Goldhirsch A, Colleoni M.

Clin Breast Cancer. 2018 Aug;18(4):328-335. doi: 10.1016/j.clbc.2018.01.010. Epub 2018 Feb 2.

PMID:
29486983
14.

Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.

Mazzanti A, Maragna R, Vacanti G, Kostopoulou A, Marino M, Monteforte N, Bloise R, Underwood K, Tibollo V, Pagan E, Napolitano C, Bellazzi R, Bagnardi V, Priori SG.

J Am Coll Cardiol. 2017 Dec 19;70(24):3010-3015. doi: 10.1016/j.jacc.2017.10.025.

15.

Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer.

Criscitiello C, Bagnardi V, Pruneri G, Vingiani A, Esposito A, Rotmensz N, Curigliano G.

Eur J Cancer. 2017 Dec;87:164-171. doi: 10.1016/j.ejca.2017.10.011. Epub 2017 Nov 15.

PMID:
29154173
16.

Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway.

Botteri E, Støer NC, Sakshaug S, Graff-Iversen S, Vangen S, Hofvind S, de Lange T, Bagnardi V, Ursin G, Weiderpass E.

BMJ Open. 2017 Nov 15;7(11):e017639. doi: 10.1136/bmjopen-2017-017639.

17.
18.

Metabolomic Profiling of Long-Term Weight Change: Role of Oxidative Stress and Urate Levels in Weight Gain.

Menni C, Migaud M, Kastenmüller G, Pallister T, Zierer J, Peters A, Mohney RP, Spector TD, Bagnardi V, Gieger C, Moore SC, Valdes AM.

Obesity (Silver Spring). 2017 Sep;25(9):1618-1624. doi: 10.1002/oby.21922. Epub 2017 Jul 31.

19.

Patterns of use and durability for the Mitroflow aortic valve: a systematic review of the literature.

Fischlein T, Pfeiffer S, Bagnardi V, Santarpino G.

J Cardiovasc Surg (Torino). 2017 Dec;58(6):916-930. doi: 10.23736/S0021-9509.17.09920-7. Epub 2017 May 26. Review.

PMID:
28548475
20.

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

Pruneri G, Lazzeroni M, Bagnardi V, Tiburzio GB, Rotmensz N, DeCensi A, Guerrieri-Gonzaga A, Vingiani A, Curigliano G, Zurrida S, Bassi F, Salgado R, Van den Eynden G, Loi S, Denkert C, Bonanni B, Viale G.

Ann Oncol. 2017 Feb 1;28(2):321-328. doi: 10.1093/annonc/mdw623.

PMID:
28426105
21.

Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.

Mazzanti A, Ng K, Faragli A, Maragna R, Chiodaroli E, Orphanou N, Monteforte N, Memmi M, Gambelli P, Novelli V, Bloise R, Catalano O, Moro G, Tibollo V, Morini M, Bellazzi R, Napolitano C, Bagnardi V, Priori SG.

J Am Coll Cardiol. 2016 Dec 13;68(23):2540-2550. doi: 10.1016/j.jacc.2016.09.951.

22.
23.

HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence.

Criscitiello C, Bagnardi V, Viale G, Disalvatore D, Rotmensz N, Esposito A, Goldhirsch A, Curigliano G.

Anticancer Res. 2016 Jul;36(7):3537-40.

PMID:
27354620
24.

De novo noncutaneous malignancies after kidney transplantation are associated with an increased risk of graft failure: results from a time-dependent analysis on 672 patients.

Cena T, Musetti C, Quaglia M, Magnani C, Stratta P, Bagnardi V, Cantaluppi V.

Transpl Int. 2016 Oct;29(10):1085-93. doi: 10.1111/tri.12813. Epub 2016 Aug 1.

25.

Impact of autoimmune diseases on outcome of patients with early breast cancer.

Criscitiello C, Bagnardi V, Esposito A, Gelao L, Santillo B, Viale G, Rotmensz N, Goldhirsch A, Curigliano G.

Oncotarget. 2016 Aug 9;7(32):51184-51192. doi: 10.18632/oncotarget.9966.

26.

Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.

Mazzanti A, Maragna R, Faragli A, Monteforte N, Bloise R, Memmi M, Novelli V, Baiardi P, Bagnardi V, Etheridge SP, Napolitano C, Priori SG.

J Am Coll Cardiol. 2016 Mar 8;67(9):1053-8. doi: 10.1016/j.jacc.2015.12.033.

27.

Erratum to: Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort Analysis.

De Lorenzi F, Loschi P, Bagnardi V, Rotmensz N, Hubner G, Mazzarol G, Orecchia R, Galimberti V, Veronesi P, Colleoni MA, Toesca A, Peradze N, Mario R.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):1056. Epub 2016 Feb 22. No abstract available.

PMID:
26903046
28.

Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort Analysis.

De Lorenzi F, Loschi P, Bagnardi V, Rotmensz N, Hubner G, Mazzarol G, Orecchia R, Galimberti V, Veronesi P, Colleoni MA, Toesca A, Peradze N, Mario R.

Ann Surg Oncol. 2016 Jun;23(6):1852-9. doi: 10.1245/s10434-016-5124-4. Epub 2016 Feb 2. Erratum in: Ann Surg Oncol. 2016 Dec;23 (Suppl 5):1056.

PMID:
26842491
29.

Predictors of advanced colorectal neoplasia at initial and surveillance colonoscopy after positive screening immunochemical faecal occult blood test.

Botteri E, Crosta C, Bagnardi V, Tamayo D, Sonzogni AM, De Roberto G, de Leone A, Lowenfels A, Maisonneuve P.

Dig Liver Dis. 2016 Mar;48(3):321-6. doi: 10.1016/j.dld.2015.11.020. Epub 2015 Dec 2.

PMID:
26739617
30.

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.

Pruneri G, Vingiani A, Bagnardi V, Rotmensz N, De Rose A, Palazzo A, Colleoni AM, Goldhirsch A, Viale G.

Ann Oncol. 2016 Feb;27(2):249-56. doi: 10.1093/annonc/mdv571. Epub 2015 Nov 23.

PMID:
26598540
31.

Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies.

Rota M, Rumi F, Bagnardi V, Dal Maso L, Zucchetto A, Levi F, La Vecchia C, Tavani A.

BJOG. 2016 Jan;123(2):285-92. doi: 10.1111/1471-0528.13717. Epub 2015 Nov 6.

32.

Oncological results of oncoplastic breast-conserving surgery: Long term follow-up of a large series at a single institution: A matched-cohort analysis.

De Lorenzi F, Hubner G, Rotmensz N, Bagnardi V, Loschi P, Maisonneuve P, Venturino M, Orecchia R, Galimberti V, Veronesi P, Rietjens M.

Eur J Surg Oncol. 2016 Jan;42(1):71-7. doi: 10.1016/j.ejso.2015.08.160. Epub 2015 Sep 8.

PMID:
26382101
33.

Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer: A Biologic Study.

Balduzzi A, Bagnardi V, Sandri MT, Dellapasqua S, Cardillo A, Montagna E, Cancello G, Iorfida M, Ghisini R, Viale G, Intra M, Luini A, Goldhirsch A, Colleoni M.

Clin Breast Cancer. 2015 Oct;15(5):e257-62. doi: 10.1016/j.clbc.2015.03.007. Epub 2015 Apr 30.

PMID:
26362840
34.

Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience.

Montagna E, Bagnardi V, Rotmensz N, Viale G, Cancello G, Palazzo A, Galimberti V, Veronesi P, Luini A, Mastropasqua MG, Santillo B, Goldhirsch A, Colleoni M.

Clin Breast Cancer. 2015 Dec;15(6):440-7. doi: 10.1016/j.clbc.2015.07.003. Epub 2015 Jul 10.

PMID:
26255932
35.

Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer.

Cancello G, Bagnardi V, Sangalli C, Montagna E, Dellapasqua S, Sporchia A, Iorfida M, Viale G, Barberis M, Veronesi P, Luini A, Intra M, Goldhirsch A, Colleoni M.

Clin Breast Cancer. 2015 Aug;15(4):259-65. doi: 10.1016/j.clbc.2015.03.002. Epub 2015 Mar 18.

PMID:
25933934
36.

Outcome of Immediate Breast Reconstruction in Patients With Nonendocrine-Responsive Breast Cancer: A Monoinstitutional Case-Control Study.

Aurilio G, Bagnardi V, Nolè F, Pruneri G, Graffeo R, Petit JY, Cullurà D, Martella S, Locatelli M, Iera M, Rey P, Curigliano G, Rotmensz N, Munzone E, Goldhirsch A.

Clin Breast Cancer. 2015 Oct;15(5):e237-41. doi: 10.1016/j.clbc.2015.03.009. Epub 2015 Mar 24.

PMID:
25908443
37.

Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine.

Curigliano G, Bagnardi V, Bertolini F, Alcalay M, Locatelli MA, Fumagalli L, Rabascio C, Calleri A, Adamoli L, Criscitiello C, Viale G, Goldhirsch A.

Breast. 2015 Jun;24(3):263-71. doi: 10.1016/j.breast.2015.02.036. Epub 2015 Mar 12.

PMID:
25772326
38.

Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology.

Intra M, Viale G, Vila J, Grana CM, Toesca A, Gentilini O, Galimberti V, Veronesi P, Luini A, Rotmensz N, Bagnardi V, Mattar D, Colleoni M.

Ann Surg Oncol. 2015 Jul;22(7):2372-7. doi: 10.1245/s10434-014-4282-5. Epub 2014 Dec 17.

PMID:
25515197
39.

Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis.

Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, Scotti L, Jenab M, Turati F, Pasquali E, Pelucchi C, Galeone C, Bellocco R, Negri E, Corrao G, Boffetta P, La Vecchia C.

Br J Cancer. 2015 Feb 3;112(3):580-93. doi: 10.1038/bjc.2014.579. Epub 2014 Nov 25.

40.

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy.

Montagna E, Bagnardi V, Viale G, Rotmensz N, Sporchia A, Cancello G, Balduzzi A, Galimberti V, Veronesi P, Luini A, Mastropasqua MG, Casadio C, Sangalli C, Goldhirsch A, Colleoni M.

Ann Oncol. 2015 Feb;26(2):307-13. doi: 10.1093/annonc/mdu528. Epub 2014 Nov 19.

PMID:
25411418
41.

Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?

Aurilio G, Bagnardi V, Graffeo R, Nolè F, Petit JY, Locatelli M, Martella S, Iera M, Rey P, Curigliano G, Rotmensz N, Munzone E, Goldhirsch A.

Anticancer Res. 2014 Nov;34(11):6677-83.

42.

Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer.

Munzone E, Bagnardi V, Rotmensz N, Sporchia A, Mazza M, Pruneri G, Intra M, Sciandivasci A, Gentilini O, Luini A, Viale G, Veronesi P, Colleoni M.

Breast Cancer Res Treat. 2014 Aug;146(3):573-82. doi: 10.1007/s10549-014-3043-2. Epub 2014 Jul 10.

PMID:
25007961
43.

Alcohol drinking and risk of leukemia-a systematic review and meta-analysis of the dose-risk relation.

Rota M, Porta L, Pelucchi C, Negri E, Bagnardi V, Bellocco R, Corrao G, Boffetta P, La Vecchia C.

Cancer Epidemiol. 2014 Aug;38(4):339-45. doi: 10.1016/j.canep.2014.06.001. Epub 2014 Jun 27. Review.

PMID:
24986108
44.

MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.

Pasquali E, García-Borrón JC, Fargnoli MC, Gandini S, Maisonneuve P, Bagnardi V, Specchia C, Liu F, Kayser M, Nijsten T, Nagore E, Kumar R, Hansson J, Kanetsky PA, Ghiorzo P, Debniak T, Branicki W, Gruis NA, Han J, Dwyer T, Blizzard L, Landi MT, Palmieri G, Ribas G, Stratigos A, Council ML, Autier P, Little J, Newton-Bishop J, Sera F, Raimondi S; M-SKIP Study Group.

Int J Cancer. 2015 Feb 1;136(3):618-31. doi: 10.1002/ijc.29018. Epub 2014 Jun 18.

45.

Outcome of male breast cancer: a matched single-institution series.

Iorfida M, Bagnardi V, Rotmensz N, Munzone E, Bonanni B, Viale G, Pruneri G, Mazza M, Cardillo A, Veronesi P, Luini A, Galimberti V, Goldhirsch A, Colleoni M.

Clin Breast Cancer. 2014 Oct;14(5):371-7. doi: 10.1016/j.clbc.2014.02.008. Epub 2014 Mar 1.

PMID:
24742826
46.

Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series.

Aurilio G, Graffeo R, Bagnardi V, Nolè F, Adamoli L, Pagani O, Gallerani E, Ferrari B, Pruneri G, Goldhirsch A.

Int J Clin Oncol. 2015 Feb;20(1):90-4. doi: 10.1007/s10147-014-0694-2. Epub 2014 Apr 12.

PMID:
24722887
47.

Prevalence and clinicopathologic correlates of O⁶-methylguanine-DNA methyltransferase methylation status in patients with triple-negative breast cancer treated preoperatively by alkylating drugs.

Fumagalli C, Della Pasqua S, Bagnardi V, Cardillo A, Sporchia A, Colleoni M, Viale G, Barberis M, Pruneri G.

Clin Breast Cancer. 2014 Aug;14(4):285-90. doi: 10.1016/j.clbc.2014.02.010. Epub 2014 Mar 2.

PMID:
24709436
48.

CT-guided bone biopsy in cancer patients with suspected bone metastases: retrospective review of 308 procedures.

Monfardini L, Preda L, Aurilio G, Rizzo S, Bagnardi V, Renne G, Maccagnoni S, Vigna PD, Davide D, Bellomi M.

Radiol Med. 2014 Nov;119(11):852-60. doi: 10.1007/s11547-014-0401-4. Epub 2014 Apr 4.

PMID:
24700152
49.

TnI-Ultra assay measurements in cancer patients: comparison with the conventional assay and clinical implication.

Salvatici M, Cardinale D, Botteri E, Bagnardi V, Mauro C, Cassatella MC, Lentati P, Bottari F, Zorzino L, Passerini R, Cipolla CM, Sandri MT.

Scand J Clin Lab Invest. 2014 Aug;74(5):385-91. doi: 10.3109/00365513.2014.898325. Epub 2014 Apr 3.

PMID:
24693994
50.

Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies.

Turati F, Galeone C, Rota M, Pelucchi C, Negri E, Bagnardi V, Corrao G, Boffetta P, La Vecchia C.

Ann Oncol. 2014 Aug;25(8):1526-35. doi: 10.1093/annonc/mdu020. Epub 2014 Mar 14. Review.

PMID:
24631946

Supplemental Content

Loading ...
Support Center